Drug details

Dartisla ODT (glycopyrrolate orally disintegrating tablets)

type of Anesthetic Premedication Agents, Anticholinergic Agents

Dartisla ODT (glycopyrrolate) is an anticholinergic indicated in adults to reduce symptoms of a peptic ulcer as an adjunct to treatment of peptic ulcer.

This drug may have the following side effects:

• diarrhea,
• fever,
• hives, 
• difficulty breathing, 
• swelling of your face, lips, tongue, or throat, 
• severe stomach pain, 
• confusion, 
• shallow breathing, 
• bloating,
• painful or difficult urination, 
• fluttering in your chest, 
• seeing halos around lights, 
• eye pain, 
• weak pulse, and
• hot and red skin
• fussiness, and
• excessive crying
• severe constipation, 
• fast or pounding heartbeats, 
• severe drowsiness, 
• In children:
• dry diapers, 

The following drugs are related to Dartisla ODT, either as a replacement or used together:

• Aciphex (rabeprazole sodium)
• Aciphex Sprinkle (rabeprazole sodium)
• Carafate Suspension (sucralfate)
• Carafate Tablets (sucralfate)
• Tagamet (cimetidine)
• Cytotec (misoprostol)
• Nexium (esomeprazole magnesium)
• Esomeprazole Magnesium Capsules (esomeprazole magnesium)
• Pepcid (famotidine)
• Zantac 360 (famotidine)
• Pepcid Injection (famotidine injection)
• Prevacid (lansoprazole)
• Prevacid NapraPAC (lansoprazole)
• Prevacid I.V. (lansoprazole for injection)
• Prilosec (omeprazole)
• Zegerid (omeprazole, sodium bicarbonate)
• Protonix (pantoprazole)
• Protonix I.V. (pantoprazole sodium)